Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Microneedle Flu Vaccine Market Size study, by Product Type (Solid Microneedle, Hollow Microneedle, Coated Microneedle, Dissolving Microneedle), by Vaccine Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine) and Regional Forecasts 2022-2028

  • BIZ4982981
  • 200 Pages
  • June 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Microneedle Flu Vaccine Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2022-2028. Micro-needles are a novel sort of dosing device that may easily overcome the problems that older formulations face. Micron-sized needles are put on a tiny dermal patch to create the microneedle device. Solid micro-needles, coated micro-needles, hollow micro-needles, dissolving micro-needles, solid are only a few of the several types of micro-needles available. The market growth is driven by key factors such as key players focusing on research and development of Micro-Needle Flu Vaccines and increasing prevalence of influenza and viral infections. For instance, Verndari, Inc received USD 1 million in funding from the US Government Agency BARDA in August 2020 to help accelerate the research and development of VaxiPatch, a dermal patch vaccination technology that may be used to treat a variety of infectious illnesses including influenza flu. Furthermore, according to statistics published by MedAlertHelp, around 5% to 20% of Americans will be diagnosed with influenza each year in 2022. In addition, according to data released by the Centers for Disease Control and Prevention in October 2021, the 2019-2020 flu season resulted in 35 million flu-related illnesses, 380,000 flu-related hospitalizations, 20,000 flu-related fatalities, and 16 million flu-related medical visits. Over the next several years, the increased burden of illnesses is expected to have a favorable influence on market growth. However, complications and risks associated with Microneedles impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Microneedle Flu Vaccine Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific is dominating the market owing to increasing clinical development of microneedle flu vaccines. However, North America is projected to be the fastest growing region due to the launch of new campaigns and initiatives by healthcare agencies to prevent the flu.

Major market players included in this report are:

Becton, Dickinson and Company

3M Company

CosMED Pharmaceuticals Co., Ltd.

OraSure Technologies, Inc.

NanoPass Technologies Limited

Corium International, Inc

FluGen, Inc.

Microdermics

Debiotech S.A

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Solid Microneedle

Hollow Microneedle

Coated Microneedle

Dissolving Microneedle

By Vaccine Type:

Trivalent Flu Vaccine

Quadrivalent Flu Vaccine

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Microneedle Flu Vaccine Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)

1.2.1. Microneedle Flu Vaccine Market, by Region, 2020-2028 (USD Million)

1.2.2. Microneedle Flu Vaccine Market, by Product Type, 2020-2028 (USD Million)

1.2.3. Microneedle Flu Vaccine Market, by Vaccine Type, 2020-2028 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Microneedle Flu Vaccine Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Microneedle Flu Vaccine Market Dynamics

3.1. Microneedle Flu Vaccine Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Key Players Focusing on Research and Development of Micro-Needle Flu Vaccines

3.1.1.2. Increasing Prevalence of Influenza and Viral Infections

3.1.2. Market Challenges

3.1.2.1. Complications and Risks Associated with Microneedles

3.1.3. Market Opportunities

3.1.3.1. Rising incidences of swine flu

3.1.3.2. increased risk of respiratory diseases and immune-deficient diseases

Chapter 4. Global Microneedle Flu Vaccine Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Microneedle Flu Vaccine Market, by Vaccine Type

6.1. Market Snapshot

6.2. Global Microneedle Flu Vaccine Market by Vaccine Type, Performance - Potential Analysis

6.3. Global Microneedle Flu Vaccine Market Estimates & Forecasts by Vaccine Type, 2018-2028 (USD Million)

6.4. Microneedle Flu Vaccine Market, Sub Segment Analysis

6.4.1. Trivalent Flu Vaccine

6.4.2. Quadrivalent Flu Vaccine

Chapter 7. Global Microneedle Flu Vaccine Market, by Product Type

7.1. Market Snapshot

7.2. Global Microneedle Flu Vaccine Market by Product Type, Performance - Potential Analysis

7.3. Global Microneedle Flu Vaccine Market Estimates & Forecasts by Product Type, 2018-2028 (USD Million)

7.4. Microneedle Flu Vaccine Market, Sub Segment Analysis

7.4.1. Solid Microneedle

7.4.2. Hollow Microneedle

7.4.3. Coated Microneedle

7.4.4. Dissolving Microneedle

Chapter 8. Global Microneedle Flu Vaccine Market, Regional Analysis

8.1. Microneedle Flu Vaccine Market, Regional Market Snapshot

8.2. North America Microneedle Flu Vaccine Market

8.2.1. U.S. Microneedle Flu Vaccine Market

8.2.1.1. Product Type breakdown estimates & forecasts, 2018-2028

8.2.1.2. Vaccine Type breakdown estimates & forecasts, 2018-2028

8.2.2. Canada Microneedle Flu Vaccine Market

8.3. Europe Microneedle Flu Vaccine Market Snapshot

8.3.1. U.K. Microneedle Flu Vaccine Market

8.3.2. Germany Microneedle Flu Vaccine Market

8.3.3. France Microneedle Flu Vaccine Market

8.3.4. Spain Microneedle Flu Vaccine Market

8.3.5. Italy Microneedle Flu Vaccine Market

8.3.6. Rest of Europe Microneedle Flu Vaccine Market

8.4. Asia-Pacific Microneedle Flu Vaccine Market Snapshot

8.4.1. China Microneedle Flu Vaccine Market

8.4.2. India Microneedle Flu Vaccine Market

8.4.3. Japan Microneedle Flu Vaccine Market

8.4.4. Australia Microneedle Flu Vaccine Market

8.4.5. South Korea Microneedle Flu Vaccine Market

8.4.6. Rest of Asia Pacific Microneedle Flu Vaccine Market

8.5. Latin America Microneedle Flu Vaccine Market Snapshot

8.5.1. Brazil Microneedle Flu Vaccine Market

8.5.2. Mexico Microneedle Flu Vaccine Market

8.6. Rest of The World Microneedle Flu Vaccine Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. Becton, Dickinson and Company

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. Product Summary

9.2.1.5. Recent Developments

9.2.2. 3M Company

9.2.3. CosMED Pharmaceuticals Co., Ltd.

9.2.4. OraSure Technologies, Inc.

9.2.5. NanoPass Technologies Limited

9.2.6. Corium International, Inc

9.2.7. FluGen, Inc.

9.2.8. Microdermics

9.2.9. Debiotech S.A

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption

List of Tables

TABLE 1. Global Microneedle Flu Vaccine Market, report scope

TABLE 2. Global Microneedle Flu Vaccine Market estimates & forecasts by Region 2018-2028 (USD Million)

TABLE 3. Global Microneedle Flu Vaccine Market estimates & forecasts by Product Type 2018-2028 (USD Million)

TABLE 4. Global Microneedle Flu Vaccine Market estimates & forecasts by Vaccine Type 2018-2028 (USD Million)

TABLE 5. Global Microneedle Flu Vaccine Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 6. Global Microneedle Flu Vaccine Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 7. Global Microneedle Flu Vaccine Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 8. Global Microneedle Flu Vaccine Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 9. Global Microneedle Flu Vaccine Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 10. Global Microneedle Flu Vaccine Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 11. Global Microneedle Flu Vaccine Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 12. Global Microneedle Flu Vaccine Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 13. Global Microneedle Flu Vaccine Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 14. Global Microneedle Flu Vaccine Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 15. U.S. Microneedle Flu Vaccine Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 16. U.S. Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 17. U.S. Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 18. Canada Microneedle Flu Vaccine Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 19. Canada Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 20. Canada Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 21. UK Microneedle Flu Vaccine Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 22. UK Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 23. UK Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 24. Germany Microneedle Flu Vaccine Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 25. Germany Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 26. Germany Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 27. RoE Microneedle Flu Vaccine Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 28. RoE Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 29. RoE Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 30. China Microneedle Flu Vaccine Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 31. China Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 32. China Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 33. India Microneedle Flu Vaccine Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 34. India Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 35. India Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 36. Japan Microneedle Flu Vaccine Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 37. Japan Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 38. Japan Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 39. RoAPAC Microneedle Flu Vaccine Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 40. RoAPAC Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 41. RoAPAC Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 42. Brazil Microneedle Flu Vaccine Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 43. Brazil Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 44. Brazil Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 45. Mexico Microneedle Flu Vaccine Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 46. Mexico Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 47. Mexico Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 48. RoLA Microneedle Flu Vaccine Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 49. RoLA Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 50. RoLA Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 51. Row Microneedle Flu Vaccine Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 52. Row Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 53. Row Microneedle Flu Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 54. List of secondary sources, used in the study of global Microneedle Flu Vaccine Market

TABLE 55. List of primary sources, used in the study of global Microneedle Flu Vaccine Market

TABLE 56. Years considered for the study

TABLE 57. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
View Details
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370
View Details
Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research